Genetic determinants and ethnic disparities in sepsis-associated acute lung injury

Proceedings of the American Thoracic Society

Volumn 2, Issue 3, 2005, Pages 195-201

  Barnes, Kathleen C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Acute lung injury; Ethnicity; Genetics; Sepsis

Indexed keywords

AFRICAN AMERICAN; ANCESTOR; CANDIDATE GENE; CASE CONTROL STUDY; COMPLEX TRAIT; CONFERENCE PAPER; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GENE; GENE ENVIRONMENT INTERACTION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENE LOCUS HETEROGENEITY; GENETIC LINE; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENETICS; HEREDITY; HIGH THROUGHPUT SCREENING; HUMAN; HYPERTENSION; INCOMPLETE PENETRANCE; INFLAMMATION; LUNG INJURY; PENETRANCE; PHENOTYPIC VARIATION; SEPSIS; SYSTEMIC DISEASE;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS;

EID: 27144489461     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200502-013AC     Document Type: Conference Paper

References (87)

1. Ely EW, Wheeler AP, Thompson BT, Ancukiewicz M, Steinberg KP, Bernard GR. Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med 2002;136:25-36.
2. Moss M, Mannino DM. Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979-1996). Crit Care Med 2002;30:1679-1685.
3. Jamerson KA. The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue. J Clin Hypertens (Greenwich) 2004;6:4-10.
4. Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF. Effect of multiple risk factors on differences between blacks and whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol 1993;137:719-732.
5. Grant EN, Lyttle CS, Weiss KB. The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health 2000;90:1923-1925.
6. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004;89:2590-2594.
7. Collins FS. What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat Genet 2004;36:S13-S15.
8. Henderson SO, Haiman CA, Mack W. Multiple Polymorphisms in the renin- angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethnic cohort. Am J Med Sci 2004;328:266-273.
9. Hooper WC, Lally C, Austin H, Benson J, Dilley A, Wenger NK, Whitsett C, Rawlins P, Evatt BL. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 1999;116:880-886.
10. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
11. Choudhry S, Ung N, Avila PC, Nazario S, Casal J, Torres A, Rodriguez-Santana JR, Fagan JK, Lilly C, Salas J, et al. Pharmacogenetic differences in response to albuterol between Puerto Rican and Mexican asthmatics. Am J Respir Crit Care Med 2005;171:563-570.
12. Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC. Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 2004;25:2467-2472.
13. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999;19:932-938.
14. Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Rothe G, Schmitz G. The common functional C(-159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun 2000;1: 405-407.
15. Caggana M, Walker K, Reilly AA, Conroy JM, Duva S, Walsh AC. Population-based studies reveal differences in the allelic frequencies of two functionally significant human interleukin-4 receptor polymorphisms in several ethnic groups. Genet Med 1999;1:267-271.
16. Tchernitchko D, Chiminqgi M, Galacteros F, Prehu C, Segbena Y, Coulibaly H, Rebaya N, Loric S. Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations. Eur J Hum Genet 2005;13:513-515.
17. Ness RB, Haggerty CL, Harger G, Ferrell R. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol 2004;160:1033-1038.
18. Nickel R, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett B, Freidhoff LR, Sengler C, Plitt J, Schleimer RP, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the CC chemokine RANTES. J Immunol 2000;164:1612-1616.
19. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, et al. Hemophilia Growth and Development Study. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
20. Samson M, Libert F, Doranz BJ, Rucker J, Liesngard C, Farber C-M, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
21. Martinson JJ, Chapman NH, Rees DC, Liu Y-T, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997;16:100-103.
22. Jeyaseelan S, Chu HW, Young SK, Worthen GS. Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun 2004;72: 7247-7256.
23. Ye S, Simon BA, Maloney JP, Zambelli-Weiner A, Gao L, Grant A, Easley RB, McVerry BJ, Tuder RM, Standiford T, Brower R, Barnes KC, and Garcia JG. 2004. Pre-B-cell colony enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2004;171:361-370.
24. Grigoryev DN, Finigan JH, Hassoun P, Garcia JG. Science review: searching for gene candidates in acute lung injury. Crit Care 2004;8: 440-447.
25. Yanagisawa R, Takano H, Inoue K, Ichinose T, Yoshida S, Sadakane K, Takeda K, Yoshino S, Yamaki K, Kumagai Y, et al. Complementary DNA microarray analysis in acute lung injury induced by lipopoly-saccharide and diesel exhaust particles. Exp Biol Med (Maywood) 2004;229:1081-1087.
26. Olman MA, White KE, Ware LB, Simmons WL, Benveniste EN, Zhu S, Pugin J, Matthay MA. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1 beta-induced IL-6 expression. J Immunol 2004;172:2668-2677.
27. Tracey KJ, Warren HS. Human genetics: an inflammatory issue. Nature 2004;429:35-37.
28. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999;27:1330-1334.
29. Arnalich F, Lopez-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM. Capiscol C, Fernandez-Capitan C, Madero R, Montiel C. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 2002;127:331-336.
30. Ma P, Chen D, Pan J, Du B. Genomic polymorphism within interleukin-1 family cytokines influences the outcome of septic patients. Crit Care Med 2002;30:1046-1050.
31. 2 interaction in the critically ill [abstract]. Am J Respir Crit Care Med 2002;165:A23.
32. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999;354:561-563.
33. Menges T, Hermans PW, Little SG, Langefeld T, Boning O, Engel J, Sluijter M, de Groot R, Hempelmann G. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet 2001;357:1096-1097.
34. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186:1522-1555.
35. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002;162:1028-1032.
36. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet 2004;41:808-813.
37. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384.
38. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riche F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561-568.
39. Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001;163:1599-1604.
40. O'Keefe GE, Hybki DL, Munford RS. The G→A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002;52:817-825.
41. Walley KR, Holmes CL, Sandford AJ, Pare PD, Russell JA. Differential association of TNF-α-308 G/A polymorphism in critically ill patients with and without septic shock. Am J Respir Crit Care Med 2002;165: A519.
42. Carratu P, Quasney MW, Stentz FB, Freire AX, Zhang Q, McArthur J, Meduri GU. TNF-α and LT-α gene polymorphisms in acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 2002;165:A474.
43. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003;33:518-521.
44. Mitchell AA, Zwick ME, Chakravarti A, Cutler DJ. Discrepancies in dbSNP confirmation rates and allele frequency distributions from varying genotyping error rates and patterns. Bioinformatics 2004;20:1022-1032.
45. Mwantembe O, Gaillard MC, Barkhuizen M, Pillay V, Berry SD, Dewar JB, Song E. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics 2001;52:249-254.
46. Max M, Pison U, Floros J. Frequency of SP-B and SP-A1 gene polymorphisms in acute respiratory distress syndrome (ARDS). Appl Cardiopulm Pathophysiol 1996;6:111-118.
47. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, Floros J. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000;58:181-191.
48. Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 2004;125:203-211.
49. Quasney MW, Waterer GW, Dahmer MK, Kron GK, Zhang Q, Kessler LA, Wunderink RG. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 2004;32:1115-1119.
50. Veletza SV, Rogan PK, TenHave T, Olowe SA, Floros J. Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B). Exp Lung Res 1996;22:489-494.
51. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-650.
52. Mathew J, Basheeruddin K, Prabhakar S. Differences in frequency of the deletion polymorphism of the angiotensin-converting enzyme gene in different ethnic groups. Angiology 2001;52:375-379.
53. Grigoryev DN, Ma SF, Irizarry RA, Ye SQ, Quackenbush J, Garcia JG. Orthologous gene-expression profiling in multi-species models: search for candidate genes. Genome Biol 2004;5:R34.
54. Jacobson JR, Garcia JG. Genomics made functional in ventilator-associated lung injury. Am J Respir Crit Care Med 2003;168:1023-1025.
55. Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton, NJ: Princeton University Press; 1994.
56. Deka R, Jin L, Shriver MD, Yu LM, DeCroo S, Hundrieser J, Bunker CH, Ferrell RE, Chakraborty R. Population genetics of dinucleotide (dC-dA)n,(dG-dT)n polymorphisms in world populations. Am J Hum Genet 1995;56:461-474.
57. Miller LH, Mason SJ, Clyde DF, McGinnis MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302-304.
58. Weinberg RB. Apolipoprotein A-1V-2 allele: association of its worldwide distribution with adult persistence of lactase and speculation on its function and origin. Genet Epidemiol 1999;17:285-297.
59. Bersaglieri T, Sabeti PC, Patterson N, Vanderploeg T, Schaffner SF, Drake JA, Rhodes M, Reich DE, Hirschhorn JN. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet 2004;74:1111-1120.
60. Hadley TJ, Peiper SC. From malaria to the chemokine receptor: the emerging physiological role of the duffy blood group antigen. Blood 1997;89:3077-3091.
61. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261:1182-1184.
62. Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224-228.
63. Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem 1995;270:25348-25351.
64. Neote K, Mak JY, Kolakowski LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood 1994;84:44-52.
65. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004;429:75-79.
66. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001;163:316-321.
67. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
68. Wright SD. CD14 and innate recognition of bacteria. J Immunol 1995;155: 6-8.
69. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002;30:969-973.
70. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999;20:976-983.
71. Gao PS, Mao XQ, Baldini M, Roberts MH, Adra CN, Shirakawa T, Holt PG, Martinez FD, Hopkin JM. Serum total IgE levels and CD14 on chromosome 5q31. Clin Genet 1999;56:164-165.
72. Leung TF, Tang NL, Sung YM, Li AM, Wong GW, Chan IH, Lam CW. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003;14:255-260.
73. Koppelman GH, Reijmerink NE, Colin Stine O, Howard TD, Whittaker PA, Meyers DA, Postma DS, Bleecker ER. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001;163:965-969.
74. Buckova D, Holla LI, Schuller M, Znojil V, Vacha J. Two CD14 promoter polymorphisms and atopic phenotypes in Czech patients with IgE-mediated allergy. Allergy 2003;58:1023-1026.
75. Woo JG, Assa'ad A, Heizer AB, Bernstein JA, Hershey GK. The -159 C→T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol 2003;112:438-444.
76. Heinzmann A, Dietrich H, Jerkic SP, Kurz T, Deichmann KA. Promoter polymorphisms of the CD14 gene are not associated with bronchial asthma in Caucasian children. Eur J Immunogenet 2003;30:345-348.
77. Sengler C, Haider A, Sommerfeld C, Lau S, Baldini M, Martinez F, Wahn U, Nickel R. Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 2003;33:166-469.
78. Hagan P, Blumenthal UJ, Dunn D, Wilkins HA. A protective role for IgE in human schhistosomiasis. In: Moqbel R, editor. Allergy and immunity to helminths. London: Taylor & Francis, Inc.; 1992.
79. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Sole D, Carvalho EM. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 2000;123:145-148.
80. Lynch NR, Hagel IA, Palenque ME, Di Prisco MC, Escudero JE, Corao LA, Sandia JA, Ferreira LJ, Botto C, Perez M, et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998;101: 217-221.
81. Marshall RP, Payne J, Ebb SW, Humphries S, Montgomery HE, Laurent GJ. Renin angiotensin system polymorphisms in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;165:A475.
82. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 1994;170:848-853.
83. Stassen NA, Leslie-Norfleet LA, Robertson AM, Eichenberger MR, Polk HCJ. Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery 2002;132:289-292.
84. Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van AH, Assmann G, Berendes E. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002;30:32-37.
85. Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Ritter M, Rothe G, Schmitz G. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 2001;29:557-561.
86. Maloney J, Strong D, Morrison J, Wang B, Hine J, Saggar R, Kraemer R, Zelazoski A, Broeckel U. Increased prevalence of variant polymorphisms in the thrombospondin-1 (TSP1) gene in acute lung injury. Am J Respir Crit Care Med 2002;165:A473.
87. Medford ARL, Thickett DR, Keen L, Bidwell J, Millar AB. Frequency of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in patients with or at risk of adult respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 2002;165:A474.